• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Raymond James Financial Inc. (Amendment)

    2/11/22 4:59:43 PM ET
    $RJF
    Investment Bankers/Brokers/Service
    Finance
    Get the next $RJF alert in real time by email
    SC 13G/A 1 thomasajamessc13garjf2022.htm SC 13G/A Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    (Amendment No.  3 )*
    RAYMOND JAMES FINANCIAL, INC.
    (Name of Issuer)

    Common Stock
    $0.01 Par Value
    (Title of Class of Securities)

    754730109
    (CUSIP Number)

    December 31, 2021
    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     ☐ Rule 13d-1(b)
     ☐ Rule 13d-1(c)
    x Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    Page
    1
    of
    5
    Pages



    CUSIP No.: 754730109
    (1)NAMES OF REPORTING PERSONS
    Thomas A. James
    (2)CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

    (a) ☐

    (b) ☐
    (3)SEC USE ONLY
    (4)CITIZENSHIP OR PLACE OF ORGANIZATION
    United States
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH:
    (5)
    SOLE VOTING POWER

    19,818,113 (1)
    (6)
    SHARED VOTING POWER

    176,230 (1) (2)
    (7)
    SOLE DISPOSITIVE POWER

    19,818,113 (1)
    (8)
    SHARED DISPOSITIVE POWER

    176,230 (1)
    (9)
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    19,994,343 (1) (2)
    (10)CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

      ☐
    (11)
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    9.6%
    (12)
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

    IN






                                 
    (1) As adjusted to reflect the issuer’s 3-for-2 stock split by means of a stock dividend effected on September 21, 2021.

    (2) Includes 162,730 shares of Common Stock owned by the spouse of the reporting person. The reporting person disclaims ownership of these shares.

    Page
    2
    of
    5
    Pages



    Item 1.
    Item 1(a)Name of Issuer:
    Raymond James Financial, Inc.
    Item 1(b)Address of Issuer’s Principal Executive Offices:
    880 Carillon Parkway
    St. Petersburg, Florida 33716
    Item 2.
    Item 2(a)Name of Person Filing:
    Thomas A. James
    Item 2(b)Address of Principal Business Office or, if None, Residence:
    Thomas A. James
    c/o Raymond James Financial, Inc.
    880 Carillon Parkway
    St. Petersburg, Florida 33716
    Item 2(c)Citizenship:
    United States
    Item 2(d)Title of Class of Securities:
    Common Stock, $0.01 Par Value
    Item 2(e)CUSIP No.:
    754730109
    Item 3.If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    Not applicable.
    Item 4.Ownership
    The information set forth in rows 5 through 11 of the cover page hereto is incorporated herein by reference.
    Page
    3
    of
    5
    Pages


    Item 5.Ownership of Five Percent or Less of a Class.
    Not applicable.
    Item 6.Ownership of More than Five Percent on Behalf of Another Person.
    Not applicable.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
    Not applicable.
    Item 8.Identification and Classification of Members of the Group.
    Not applicable.
    Item 9.Notice of Dissolution of Group.
    Not applicable.
    Item 10.Certifications.
    Not applicable.




    Page
    4
    of
    5
    Pages


    SIGNATURE
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
    Dated:  February 11, 2022
    /s/ Thomas A. James
    Thomas A. James

    Page
    5
    of
    5
    Pages
    Get the next $RJF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RJF

    DatePrice TargetRatingAnalyst
    4/30/2025$159.00Buy → Neutral
    BofA Securities
    1/7/2025$151.00 → $166.00Overweight → Neutral
    Analyst
    1/6/2025$161.00 → $185.00Neutral → Buy
    Goldman
    12/12/2024$152.00 → $169.00Overweight → Equal Weight
    Wells Fargo
    10/9/2024$146.00Mkt Perform → Mkt Outperform
    JMP Securities
    9/12/2024$138.00Overweight
    Wells Fargo
    7/8/2024Outperform → Peer Perform
    Wolfe Research
    1/10/2024$110.00 → $135.00Neutral → Overweight
    JP Morgan
    More analyst ratings